Riverwalk Village
Inspection Findings
F-Tag F0684
F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm or potential for actual harm
Based on observation, recorded review, and interview, the facility failed to ensure residents were assessed for and deemed appropriate to self-administer medications for 1 out of 3 residents reviewed for medication administration. (Resident J) Findings include:During an interview and observation on 11/17/2025 at 10:28 a.m., Resident J indicated her morning medications had been given to her between 9:00 a.m. and 9:30 a.m. On the over-the- bed table, medication cup with several pills was observed. The resident indicated she had too many pills to take in the morning at one time.During an interview on 11/17/2025 at 10:31 a.m., LPN 6 indicated she had left the medication at the bedside during the morning medication administration pass.
She indicated medications should not be left at the bedside. LPN 6 identified the medications in the medication cup as follows: amlodipine (calcium channel blocker) tablet 2.5 mg, ascorbic acid (vitamin C) tablet 500 mg, cyanocobalamin (vitamin B-12) tablet 1,000 mcg, fluoxetine capsule (anti-depressant) 40 mg, furosemide (diuretic) tablet 40 mg, losartan (hypertensive) tablet 25 mg, magnesium gluconate (supplement) tablet 27 mg, metoprolol succinate (beta blocker) tablet 12.5 mg, pramipexole (non-ergot dopamine agonist) tablet 0.5 mg. These medications were confirmed with physician's medication orders.During an interview on 11/17/2025 at 2:10 p.m., LPN 3 indicated medications were only left at the bedside if there was a physician's order.Resident J's clinical record was reviewed on 11/17/2025 2:43 p.m.
Diagnoses included chronic obstructive pulmonary disease, acute and chronic respiratory failure with hypoxia, pulmonary edema, congestive heart failure, multiple sclerosis, chronic pain, iron deficiency anemia, depression, unspecified, gastro-esophageal reflux disease, osteoarthritis, spinal stenosis, Other abnormalities of gait and mobility, Encounter for other specified aftercare, personal history of sudden cardiac arrest, presence of cardiac pacemaker, pulmonary hypertension, unspecified, chronic pain syndrome, glaucoma, hypertension, and nonrheumatic tricuspid valve insufficiency.The clinical record lacked a physician's order to leave medications at bedside.The clinical record lacked a physician's order for
the resident to self-administer medications left at bedside.A current quarterly Minimum Data Set (MDS) assessment indicated the resident was cognitively intact. A 11/14/25 quarterly Minimum Data Set (MDS) assessment indicated the resident was cognitively intact.During an interview on 11/19/2025 at 11:02 a.m.,
the DON indicated it was the facility expectation that medications were not left at the bedside. The DON indicated LPN 6 should not have left Resident J's medications at the bedside. A current policy, dated 2/2010, titled Medication Administration (Medication Pass Procedure) was provided by the DON ono 11/17/2025 at 1:42 p.m. The policy indicated the following: 11. Observed resident taking medications -Meds not left at bedside. 3.1-37(a)
Residents Affected - Few
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99) Previous Versions Obsolete
Facility ID:
If continuation sheet
Event ID:
RIVERWALK VILLAGE in NOBLESVILLE, IN inspection on recent inspection.
Found 0 violation(s). Severity: Standard violations. Status: 0 corrected, 0 pending.
Frequently Asked Questions
- What is an F-tag violation?
- F-tags are federal deficiency codes used by CMS to categorize nursing home violations. Each F-tag corresponds to a specific federal regulation (42 CFR Part 483). For example, F607 relates to abuse prevention policies, F880 relates to infection control.
- Were these violations corrected?
- Facilities must submit plans of correction and implement changes within required timeframes. CMS conducts follow-up inspections to verify corrections. Check the inspection report for specific correction dates and follow-up verification status.
- How often do nursing home inspections happen?
- CMS conducts unannounced inspections of all Medicare/Medicaid-certified nursing homes at least once per year. Additional inspections may occur based on complaints, facility-reported incidents, or follow-up to verify previous violations were corrected.
- What should families do about these violations?
- Families should: (1) Review the full inspection report for details, (2) Ask facility administration about specific corrective actions taken, (3) Check if this represents a pattern by reviewing prior inspections, (4) Compare with other facilities in NOBLESVILLE, IN, (5) Report new concerns to state authorities.
- Where can I see the full inspection report?
- Complete inspection reports are available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request copies directly from RIVERWALK VILLAGE or from the state Department of Health. Reports include deficiency codes, facility responses, and correction timelines.